We are live on ! Find out more
COYA icon

Coya Therapeutics
COYA

56 hedge funds and large institutions have $32M invested in Coya Therapeutics in 2026 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 20 increasing their positions, 11 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

82% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 11

0% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 12

3.38% less ownership

Funds ownership: 37.94% → 34.56% (-3.4%)

3% less funds holding

Funds holding: 58 → 56 (-2)

30% less capital invested

Capital invested by funds: $46M → $32M (-$14M)

Holders
56
Holders Change
-2
Holders Change %
-3.45%
% of All Funds
0.69%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
20
Reduced
11
Closed
12
Calls
$292K
Puts
–
Net Calls
+$292K
Net Calls Change
+$236K

Top Buyers

Rank Fund Capital Flow
1
PM
Prosight Management
Texas
+$1.97M
2
DCM
DME Capital Management
New York
+$1.45M
3
PMG
Private Management Group
California
+$415K
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$302K
5
PCM
Prelude Capital Management
New York
+$229K

Top Sellers

Rank Fund Capital Flow
1
AIC
AWM Investment Company
New York
-$4.21M
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$400K
3
Bank of America
Bank of America
North Carolina
-$231K
4
Walleye Capital
Walleye Capital
New York
-$215K
5
OAC
OMERS Administration Corp
Ontario, Canada
-$200K
Name Holding Trade Value Shares
Change 		Change in
Stake
DCM
1
DME Capital Management
New York
$9.2M +$1.45M +309,600 +15%
ACM
2
AIGH Capital Management
Maryland
$3.84M – – –
VCM
3
Vanguard Capital Management
Pennsylvania
$3.33M +$3.95M +844,913 New
Alyeska Investment Group
4
Alyeska Investment Group
Illinois
$3.15M – – –
PM
5
Prosight Management
Texas
$1.66M +$1.97M +420,360 New
CM
6
CM Management
Florida
$1.48M +$117K +25,000 +7%
PMG
7
Private Management Group
California
$1.45M +$415K +88,829 +32%
Geode Capital Management
8
Geode Capital Management
Massachusetts
$920K +$166K +35,414 +18%
Marshall Wace
9
Marshall Wace
United Kingdom
$890K +$2.03K +434 +0.2%
VFT
10
Vanguard Fiduciary Trust
Pennsylvania
$551K +$654K +139,886 New
Renaissance Technologies
11
Renaissance Technologies
New York
$410K +$173K +37,064 +55%
PCM
12
Prelude Capital Management
New York
$399K +$229K +49,060 +94%
JC
13
JBF Capital
Colorado
$394K – – –
Dimensional Fund Advisors
14
Dimensional Fund Advisors
Texas
$377K +$302K +64,490 +205%
Morgan Stanley
15
Morgan Stanley
New York
$338K +$151K +32,344 +61%
BlackRock
16
BlackRock
New York
$326K +$16.9K +3,623 +5%
State Street
17
State Street
Massachusetts
$314K +$48.2K +10,303 +15%
6CM
18
683 Capital Management
New York
$276K -$47.4K -10,128 -13%
XT
19
XTX Topco
Cayman Islands
$187K +$66.7K +14,268 +43%
Jones Financial Companies
20
Jones Financial Companies
Missouri
$178K +$186K +39,883 +786%
ACM
21
ADAR1 Capital Management
Texas
$161K +$191K +40,900 New
Squarepoint
22
Squarepoint
New York
$159K -$115K -24,685 -38%
Northern Trust
23
Northern Trust
Illinois
$159K – – –
Susquehanna International Group
24
Susquehanna International Group
Pennsylvania
$155K -$400K -85,515 -69%
LCAM
25
Long Corridor Asset Management
Hong Kong
$153K – – –
1
2 3

COYA Hedge Fund Activity: Q1 2026 in Review

56 of the 8,127 institutional investors tracked by Wall St. Rank reported a position in Coya Therapeutics (COYA) for Q1 2026, worth a combined $32M — down 30% from $46M a quarter earlier.

Fund positioning in COYA was balanced in Q1 2026: 12 funds opened new positions, 12 closed out, 20 added to existing stakes and 11 trimmed.

The largest buyer was Prosight Management, opening a new position worth an estimated $1.97M. The largest seller was AWM Investment Company, exiting entirely with an estimated $4.21M sold.

  • 56 institutional investors held Coya Therapeutics (COYA) as of Q1 2026, down from 58 in Q4 2025.
  • Funds reported $32M of Coya Therapeutics stock for Q1 2026, down 30% quarter-over-quarter.
  • 12 funds opened new Coya Therapeutics positions in Q1 2026 and 12 closed out, a net change of 0 holders.
  • The largest Coya Therapeutics buyer in Q1 2026 was Prosight Management, an estimated $1.97M added.
  • The largest Coya Therapeutics seller in Q1 2026 was AWM Investment Company, an estimated $4.21M sold.

Based on aggregated 13F filings for Q1 2026.